Pre-eclampsia and the vascular endothelial growth factor: a new aspect

Area of Science:

• Obstetrics and Gynecology
• Vascular Biology
• Reproductive Medicine

Background:

• Pre-eclampsia (PE) is a serious pregnancy disorder affecting 3-14% globally, causing significant maternal and neonatal mortality.
• Early identification of high-risk pregnancies for PE is a critical goal in obstetrics.
• Vascular Endothelial Growth Factor (VEGF) plays a key role in neovascularization and is implicated in various pathological processes, including PE.

Purpose of the Study:

• To review the relationship between circulating vascular endothelial growth factor (VEGF) and pre-eclampsia (PE).
• To summarize current understanding of VEGF's role in PE pathogenesis, diagnosis, and prediction.
• To highlight the potential of VEGF as a biomarker for identifying pregnancies at high risk for PE.

Main Methods:

• Review of existing scientific literature on pre-eclampsia and VEGF.
• Analysis of studies investigating circulating VEGF levels in relation to PE.
• Synthesis of findings on VEGF's role in neovascularization and PE development.

Main Results:

• Alterations in circulating VEGF levels are associated with pre-eclampsia.
• VEGF is involved in the neovascularization processes critical to PE pathogenesis.
• Circulating VEGF levels may serve as an indicator for predicting PE development.

Conclusions:

• Circulating VEGF levels show promise as a predictive marker for pre-eclampsia.
• Understanding VEGF's role is vital for improving early diagnosis and management of PE.
• Further research into VEGF may lead to better strategies for identifying and potentially preventing PE.